Optum
| Company type | Subsidiary |
|---|---|
| Industry | Healthcare, Technology, Pharmacy Benefit Management |
| Founded | 2011 |
| Founder | UnitedHealth Group |
| Headquarters | United States |
Area served | United States, United Kingdom |
Key people | Patrick Conway (CEO as of April 2025) |
| Products | Technology solutions, pharmacy benefit management, direct healthcare delivery |
| Parent | UnitedHealth Group |
Optum, Inc. is a U.S.-based healthcare enterprise specializing in technology solutions, pharmacy benefit management, and direct healthcare delivery.
Established in 2011 as a subsidiary by consolidating UnitedHealth Group’s pharmacy and care delivery operations, Optum functions through three primary divisions: OptumHealth, OptumInsight, and OptumRx. By 2017, it accounted for 44% of UnitedHealth Group’s earnings. In 2019, Optum surpassed $100 billion in revenue for the first time, marking an 11.1% increase year-over-year and becoming the fastest-expanding segment within UnitedHealth.
At the beginning of 2019, Optum initiated legal action over trade secrets against ex-executive David William Smith following his move to Haven Healthcare, a collaborative venture formed by Amazon, JPMorgan Chase, and Berkshire Hathaway.
Corporate Structure
Optum is organized into three key segments: OptumRx, OptumHealth, and OptumInsight. These units concentrate on areas such as data analytics, pharmacy care management, population health strategies, healthcare service delivery, and operational efficiency. Its clientele includes employers, government bodies, health insurers, life sciences organizations, healthcare providers, and individual consumers. The Optum Serve branch specifically caters to U.S. government agencies by providing health-related services.
Significant Acquisitions
Since its inception in 2011, Optum has pursued growth through targeted acquisitions to strengthen its pharmacy benefit management and care delivery capabilities:
- January 2013: Collaborated with Mayo Clinic to establish OptumLabs aimed at advancing health data research.
- October 2013: Joined forces with Dignity Health to create Optum360, focusing on revenue cycle management solutions.
- February 2014: Obtained a controlling interest in Audax Health Solutions (later rebranded as Rally Health), enhancing patient engagement platforms.
- April 2015: Acquired MedExpress, an urgent care provider.
- July 2015: Merged Catamaran Pharmacy Benefit Manager into the OptumRx division.
- January 2017: Expanded ambulatory surgery center network by acquiring Surgical Care Affiliates.
- August 2017: Purchased the healthcare business of Advisory Board Company to augment advisory service offerings.
- December 2017: Integrated DaVita Medical Group from DaVita Inc., broadening its physician practice network.
- September 2019: UnitedHealth Group acquired Equian for $3.2 billion to enhance payment integrity within Optum.
- January 2021: Completed acquisition of Change Healthcare LLC for $13 billion (including debt), combining it with OptumInsight to bolster technology and analytics capabilities.
- August 2021: Added Solutran LLC to improve payment processing solutions.
- May 2022: Acquired Atrius Health, an independent physician-led organization.
- June 2022: Through Bordeaux UK Holdings II Limited (an Optum affiliate), purchased EMIS Health for $1.5 billion to expand its presence in the UK market.
- July 2022: Acquired three midsize physician-led groups—Caremount Medical (NY), Riverside Medical Care (NJ), and ProHealth Medical Group (CT)—integrating them under the Optum Medical Care brand while maintaining a low public association with UnitedHealth Group.
- June 2023: Reached agreement to acquire home health provider Amedisys for $3.3 billion, outbidding a competing offer from Option Care.
Optum’s vertically integrated approach—merging managed care services with ambulatory care delivery and pharmacy benefit management—has fueled substantial market share expansion and influenced broader industry consolidation trends such as the CVS-Aetna and Cigna-Express Scripts mergers. This integrated model has delivered competitive advantages by reducing costs and enhancing positioning in the marketplace.
Nevertheless, this vertical integration strategy has attracted regulatory examination; the Federal Trade Commission (FTC) has accused leading PBMs including OptumRx of engaging in anticompetitive behaviors that potentially elevate drug prices through conflicts of interest and exclusive agreements. Additionally, the American Medical Association (AMA) has voiced concerns that mergers like CVS-Aetna diminish competition within pharmacy benefit management and insurance sectors, which may lead to higher consumer expenses and fewer options.
Leadership
- July 2011: Larry Renfro was named CEO of Optum.[1]
- March 2018: Larry Renfro announced his intention to resign.[2]
- July 2018: Sir Andrew Witty was appointed as the new CEO of Optum.[3]
- February 2021: Andrew Witty advanced to CEO of UnitedHealth Group, leaving the Optum CEO position unfilled.[4]
- April 2024: Heather Cianfrocco took on the role of Optum CEO.[5]
- April 2025: Patrick Conway succeeded Heather Cianfrocco as Optum CEO, while she transitioned to EVP overseeing governance, compliance, and information security.[6]
Haven lawsuit
In early 2019, UnitedHealth Group initiated legal action against former Optum executive David William Smith to prevent his employment at Haven, a healthcare initiative supported by Amazon, JP Morgan, and Berkshire Hathaway. The suit referenced a noncompete clause and concerns over direct rivalry.[7] The court opted for arbitration instead of litigation, temporarily halting the lawsuit.[8]
This dispute brought attention to trade secret conflicts amid the healthcare sector’s vertical consolidation and underscored competitive challenges for pharmacy benefit managers amid regulatory attention on escalating costs.[9] Testimony from Haven's COO, later made public, shed light on strategic obstacles within the healthcare marketplace.[10]
Allegations of racial bias
A 2019 investigation published in Science revealed that a healthcare algorithm used to manage care for more than 200 million Americans annually demonstrated substantial bias against Black patients. The algorithm reportedly undervalued their healthcare needs relative to white patients, leading to reduced spending despite comparable health statuses. Consequently, the system inaccurately classified Black patients as less ill. Optum, the developer of this algorithm, asserts that its technology assists clinicians in enhancing patient care every day.